Document is current
Any future updates will be listed below
-
Authors
Bian, Yanqin
Chen, Xi
Cao, Hongyan
Xie, Dong
Zhu, Meiping
Yuan, Nong
Lu, Lu
Lu, Bingjie
Wu, Chao
Bahaji Azami, Nisma Lena
Wang, Zheng
Wang, Huijun
Zhang, Yeqing
Li, Kun
Ye, Guan
Sun, Mingyu
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03814629 at ClinicalTrials.govDocuments that mention this clinical trial
A correlational study of Weifuchun and its clinical effect on intestinal flora in precancerous lesions of gastric cancer
https://doi.org/10.1186/s13020-021-00529-9
-
Funding
Funding for this research was provided by:
Science and Technology Commission of Shanghai Municipality (15DZ1900104, 19401972300)
State Administration of Traditional Chinese Medicine of the People's Republic of China (2017-124)
Collaborative Innovation Center for Modern Science and Technology and Industrial Development of Jiangxi Traditional Medicine (2017)
Shanghai University of Traditional Chinese Medicine (2020, 2020)
Key Disciplines of Liver and Gall Bladder Diseases and Key Laboratory of Chronic Deficiency Liver Disease of State Administration of Traditional Chinese Medicine of the People’s Republic of China
- License Information
-
More Information
Article History
Received: 30 May 2021
Accepted: 31 October 2021
First Online: 20 November 2021
Declarations
:
: The study was approved by the Ethics Committees of Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine (No. 2016-478-29-01) and performed in accordance with the Declaration of Helsinki. All patients were fully informed of the study and informed consent were obtained from all patients.
: Not applicable.
: The authors declare that they have no competing interests.
